Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Phys Topicsdermatological

Phys · dermatological

Vasculitic Skin Lesions

Also known as Vasculitic Skin Lesions · vasculitic skin lesions

Consultant-physician depth guide to Vasculitic Skin Lesions for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

medium7 referencesUpdated 26 July 202610 min readVerification in progress

Practise this topic

  • 10 MCQs
  • SAQ
  • Viva
  • Case

Your progress

Saved on this device.

Practise this topic

  • MCQ practice1
  • Short-answer question1
  • Viva station1
  • Clinical case1

Target exams

FRACP DWEFRACP DCEMRCP Part 2ABIM Internal Medicine

Red flags

  • Missed urgency or delayed escalation in Vasculitic Skin Lesions turns a salvageable presentation into preventable harm
  • Treating the label without confirming the mechanism leads to wrong therapy in Vasculitic Skin Lesions
  • Ignoring multimorbidity and drug interactions while managing Vasculitic Skin Lesions is a classic exam and clinical trap
  • Failing to document the shared plan and safety-net advice after Vasculitic Skin Lesions loses follow-through
  • Using recalled thresholds without a cited source is forbidden — verify before acting
On this page
Study tools

Your progress

Saved on this device.

Practise this topic

  • MCQ practice1
  • Short-answer question1
  • Viva station1
  • Clinical case1

Target exams

FRACP DWEFRACP DCEMRCP Part 2ABIM Internal Medicine

Red flags

  • Missed urgency or delayed escalation in Vasculitic Skin Lesions turns a salvageable presentation into preventable harm
  • Treating the label without confirming the mechanism leads to wrong therapy in Vasculitic Skin Lesions
  • Ignoring multimorbidity and drug interactions while managing Vasculitic Skin Lesions is a classic exam and clinical trap
  • Failing to document the shared plan and safety-net advice after Vasculitic Skin Lesions loses follow-through
  • Using recalled thresholds without a cited source is forbidden — verify before acting
The one-line answer

Vasculitic skin lesions are the visible face of blood vessel inflammation, and the morphology is the single most informative clue — it localises the vessel size and narrows the work-up. The move that wins the case: confirm the lesion is vasculitic (not infectious, thrombotic or traumatic), judge the vessel size, screen the kidney on every patient (urinalysis, blood pressure, renal function), and find the cause. Palpable purpura is small-vessel vasculitis; retiform purpura is occlusive vasculopathy — a different disease and a different drug.[1][3]

Meet the patient

A 58-year-old woman arrives with a one-week history of palpable purpura on her lower legs, arthralgia, abdominal pain, and a new finding of microscopic haematuria with red cell casts and a creatinine of 180 micromol per litre. The registrar reaches for a topical steroid and an antihistamine.[2][3]

The examiner's question: "What is the morphology telling you, what must you biopsy, and what is the first screening test you must not forget?" Biopsy early and biopsy twice — one for histology, one for immunofluorescence — and never skip the urinalysis.[3]

Physician Medicine Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Physician Medicine fellowship library.

Sign in to continueSee pricing
References7ShowHide
  1. [1]Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis N Engl J Med, 2010.PMID 20647199
  2. [2]Robson JC, Grayson PC, Ponte C, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis Arthritis Rheumatol, 2022.PMID 35106964
  3. [3]Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides Arthritis Rheum, 2013.PMID 23045170
  4. [4]Di Rocco M, Fantasia AR, Taro M, Loy A, et al. Systemic lupus erythematosus-like disease in a 6-year-old boy with prolidase deficiency J Inherit Metab Dis, 2007.PMID 17570078
  5. [8]Erol V, Güzel Z, Akgün İE, Ecer G Hydroxyurea-Associated Wunderlich Syndrome in Triple-Negative Myelofibrosis: A Case Report and Literature Review Case Rep Hematol, 2026.PMID 42182820
  6. [9]Agüera-Sánchez A, Del Carmen Brufau-Redondo M, Poblet E Whipple's Disease: Panniculitis Among Other Dermatoses. A Case Report and Literature Review J Cutan Pathol, 2026.PMID 41631710
  7. [10]Costacurta L, Di Biagio A, Taramasso L Cutaneous manifestations associated with HIV preexposure prophylaxis: what to expect and when to worry Curr Opin Infect Dis, 2026.PMID 41397237

Test yourself

Practise what you just read

  • 10 MCQs
  • SAQ
  • Viva
  • Case
Physician Medicine Pro

$29/ monthor $279 / year

The complete Physician Medicine library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousSkin Signs of Internal MalignancydermatologicalNextEpilepsyneurological